15 November 2019
Special Focus Issue of Nanomedicine highlights how nanomedicine is used in organ transplantation and regenerative surgery
The Future Science Group (FSG) published journal, Nanomedicine, has announced the release of a Special Focus Issue entitled ‘Nanomedicine in Organ Transplantation and Regenerative Surgery – Advances, Applications and Future Directions’, highlighting the applications of nanomedicines for therapeutic, diagnostic and monitoring strategies in solid organ transplantation as well covering biocompatibility and nanopharmaceutics.
Nanomedicine is releasing a Special Focus Issue on ‘‘Nanomedicine in Organ Transplantation and Regenerative Surgery – Advances, Applications and Future Directions’ which hopes to bring together many aspects of medicine with nanomedical initiatives in transplant and regenerative surgery.
A highlight from the issue includes a timely review on the development of perfluorocarbon nanocolloids for oxygen delivery, to improve outcomes in organ salvation and preservation for transplantation. The authors discuss innovative methods of improving the carriers using pharmaceutics. Another highlight is a review article exploring nanotoxicity in transplant medicine in an effort to further understand the behavior of nanoparticles in biological systems and a commentary article on nanopharmceuticals for improving patient care.
We are delighted to have worked with Guest Editors Dr. Vijay Gorantla and Dr. Jelena Janjic for the Special Focus Issue. Jelena Janjic commented: “If there is an ultimate goal for the issue, it is to open up an awareness in such a way that people who are already developing molecular imaging strategies could consider working and solving problems with their technology in regenerative medicine”.
Lucy Chard, Commissioning Editor for Nanomedicine, further added: “We are delighted to publish this Special Focus Issue which encourages innovation in such an important field to bring about better therapeutics and care to improve patient outcomes in transplant medicine. It has been a pleasure to work with Jelena Janjic and Vijay Gorantla, and all the contributing authors, to produce such a timely and insightful issue that we hope will ultimately lead to significant advances in the nanomedical and transplant fields”.
Nanomedicine has been working with to further the collaborative effort and facilitate the reaching of a wider audience. Interviews with the authors and ‘Peek behind the paper’ features will be included as the site covers the publication of the issue giving an exclusive insight into the work.
The Guest Editors’ free-access Foreword article is available online here: https://www.futuremedicine.com/doi/10.2217/nnm-2019-0338
The full issue is available online here: https://www.futuremedicine.com/toc/nnm/current
Nanomedicine is a MEDLINE-indexed journal, with an impact factor of 4.717 (2018). It is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. https://www.futuremedicine.com/journal/nnm
RegMedNet is a community site that unites the diverse regenerative medicine community, working with journals and seeking to educate and inspire to help this exciting field move forward at an even faster rate. https://www.regmednet.com/
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.